| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8244222 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 8 Pages |
Abstract
Conclusion: Local failure is a major problem in EHCC, suggesting the need for more intense radiation schedules and better radiosensitizing strategies. Because R1 resection appears to convey no benefit, it appears that surgery should be contemplated only when an R0 resection is likely. Borderline-resectable patients might be better served by neoadjuvant therapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Merav A. M.D., Kent A. M.P.H., M.S., Eyad Abu-Isa, Theodore S. M.D., Ph.D., James M.D., Mark M.D., Edgar M.D.,